Onconetix, Inc. Deferred Costs, Current
Onconetix, Inc. (ONCO) had Deferred Costs, Current of $366.11 thousand as of 2023-03-31, per its 10-Q filed 2023-05-12.
Discontinued › Balance Sheet › Assets › Assets, Current › Deferred Costs, Current
us-gaap:DeferredCostsCurrent · last filed 2023-05-12
- 2023-03-31: Deferred Costs, Current $366.11K.
- 2022-09-30: Deferred Costs, Current $176.30K.
- 2022-06-30: Deferred Costs, Current $238.80K.
- 2022-03-31: Deferred Costs, Current $238.80K.
| Period end | Deferred Costs, Current |
|---|---|
| 2023-03-31 | $366.11K 10-Q · filed 2023-05-12 |
| 2022-09-30 | $176.30K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $238.80K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $238.80K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $757.65K 10-K · filed 2023-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |